Tue. 21 May 2024, 4:21pm ET
Benzinga
Biotech, News, Events, General
Baseline characteristics reflect a PAH population with significant disease
Topline data from Phase 2b portion of IMPAHCT study to be released in June 2024
Enrollment into the Phase 3 portion of IMPAHCT continues at more than 120 sites globally